Fibromyalgic syndromes: Could growth hormone therapy be beneficial?

Pediatric Endocrinology Reviews

Volumn 6, Issue SUPPL. 4, 2009, Pages 529-533

  Cuatrecasas, Guillem ^a  

^a CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Aetiology; Fibromyalgia; Growth hormone; Growth hormone deficiency; IGFI; Mechanism of action; Syndromes

Indexed keywords

AMITRIPTYLINE; GROWTH HORMONE; MYOSIN HEAVY CHAIN; OPIATE RECEPTOR; PLACEBO; PROOPIOMELANOCORTIN; SOMATOMEDIN C; TESTOSTERONE; TRAMADOL;

ADRENERGIC SYSTEM; ANEMIA; ARTHRALGIA; ASTHENIA; AUTOIMMUNITY; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; EDEMA; ELECTROMYOGRAPHY; FATIGUE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; HIPPOCAMPUS; HORMONAL THERAPY; HUMAN; HYPERSENSITIVITY; MUSCLE BIOPSY; PAIN; PATHOGENESIS; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; FEMALE; FIBROMYALGIA; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67849092015     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172
2. Martinez-Lavin M. Overlap of fibromyalgia with other medical conditions. Curr Pain Headache Rep 2001;5:347-350
3. Carmona L, Ballina J, Gabriel R, Laffon A. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001;60:1040-1045 (Pubitemid 32989176)
4. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6-21 (Pubitemid 41113954)
5. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003; 30:1318-1325 (Pubitemid 36666360)
6. Thomas E, Ginies P, Blotman F. Fibromyalgia as a national issue: the French example. Baillieres Best Pract Res Clin Rheumatol 1999;13:525-529 (Pubitemid 30052727)
7. Department of Health. The Musculoskeletal Services Framework. London: Department of Health, 2006
8. Bennett RM. Hypothalamic-pituitary-growth hormone axis dysfunction in fibromyalgia. Presented at the National Fibromyalgia Research Association's Subgroups in Fibromyalgia Symposium, Portland, OR, USA 1999
9. Staud R, Robinson ME, Price DD. Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 2007;8:893-901 (Pubitemid 350008124)
10. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007;27:10000-10006
11. Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ. Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 2008;35:1371-1377 (Pubitemid 352000787)
12. Bennett RM. Beyond fibromyalgia: ideas on etiology and treatment. J Rheumatol 1989;19:185-191
13. Buskila D, Sarzi-Puttini P. Fibromyalgia and autoimmune diseases: the pain behind autoimmunity. Isr Med Assoc J 2008;10:77-78 (Pubitemid 351649473)
14. Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 1997;24:1384-1389
15. Leal-Cerro A, Povedano J, Astorga R, Gonzalez M, Silva H, Garcia-Pesquera F, Casanueva FF, Dieguez C. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab 1999;84:3378-3381 (Pubitemid 30646970)
16. Denko CW, Malemud CJ. Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int 2005;25:146-151 (Pubitemid 40468939)
17. Yuen KC, Bennett RM, Hryciw CA, Cook MB, Rhoads SA, Cook DM. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels? Growth Horm IGF Res 2007;17:82-88
18. Paiva ES, Deodhar A, Jones KD, Bennett R. Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum 2002;46:1344-1350 (Pubitemid 34525844)
19. Ferraccioli G, Guerra P, Rizzi V, Baraldo M, Salaffi F, Furlanut M, Bartoli E. Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. J Rheumatol 1994;21:1332-1334
20. Griep EN, Boersma JW, de Kloet ER. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheumatol 1994;21:2125-2130 (Pubitemid 24352364)
21. Dinser R, Halama T, Hoffmann A. Stringent endocrinological testing reveals subnormal growth hormone secretion in some patients with fibromyalgia syndrome but rarely severe growth hormone deficiency. J Rheumatol 2000;27:2482-2488 (Pubitemid 30765380)
22. McCall-Hosenfeld JS, Goldenberg DL, Hurwitz S, Adler GK. Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. J Rheumatol 2003;30:809-814 (Pubitemid 36402777)
23. Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998;104:227-231 (Pubitemid 28163166)
24. Cuatrecasas G, Riudavets C, Guell MA, Nadal A. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study. BMC Musculoskelet Disord 2007;8:119
25. Lathe R. Hormones and the hippocampus. J Endocrinol 2001;169:205-231
26. Sverrisdottir YB, Elam M, Caidahl K, Soderling AS, Herlitz H, Johannsson G. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults. J Hypertens 2003;21:1905-1914
27. Chrousos GP, Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 2007;10:213-219 (Pubitemid 46789478)
28. Przewlocki R, Przewlocka B. Opioids in neuropathic pain. Curr Pharm Des 2005;11:3013-3025
29. Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007;148:1574-1581 (Pubitemid 46457104)
30. Aberg ND, Johansson UE, Aberg MA, Hellstrom NA, Lind J, Bull C, lsgaard J, Anderson MF, Oscarsson J, Eriksson PS. Peripheral infusion of insulin-like growth factor-I increases the number of newborn oligodendrocytes in the cerebral cortex of adult hypophysectomized rats. Endocrinology 2007;148:3765-3772
31. Chesik D, De Keyser J, Wilczak N. Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J Mol Neurosci 2008;35:81-90
32. Isgaard J, Aberg D, Nilsson M. Protective and regenerative effects of the GH/IGF-I axis on the brain. Minerva Endocrinol 2007;32:103-113
33. Webb SM, de Andrés-Aguayo I, Rojas-García R, Ortega E, Gallardo E, Mestrón A, Serrano-Munuera C, Casamitjana R, Illa I. Neuromuscular dysfunction in adult growth hormone deficiency. Clin Endocrinol (Oxf) 2003;59:450-458 (Pubitemid 37188175)
34. Staud R. Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr Pharm Des 2006;12:23-27
35. McKoy G, Ashley W, Mander J, Yang SY, Williams N, Russell B, Goldspink G. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 1999;516:583-592 (Pubitemid 29204460)
36. LeRoith D, Roberts CT, Jr. Insulin-like growth factor I (IGF-I): a molecular basis for endocrine versus local action? Mol Cell Endocrinol 1991;77:C57-C61
37. Stewart CE, Rotwein P. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 1996;271:11330-11338 (Pubitemid 26155970)